The DOI matches its Crossref record.
THE ASSOCIATION OF PERIODIC PARALYSIS AND HYPERTHYROIDISM IN JAPAN
Abstract
ALTHOUGH periodic paralysis is a rare disorder, its association with hyperthyroidism has been reported by several investigators (1–15). In reviewing the literature, it was found that only about 30 such cases have been reported from the United States and Europe, whereas more than 70 cases have been reported from Japan. Possibly the association of these two disorders is less rare in Japan. As the Japanese reports were all concerned with relatively small numbers of patients with hyperthyroidism, the incidence of the association of these two disorders in Japan could not be estimated. In order to obtain a fairly good estimate, the incidence of periodic paralysis among 6,333 cases of hyperthyroidism operated upon in three thyroid hospitals in Japan was studied. These hospitals were located in different parts of country—Noguchi Hospital in Beppu, Kyushu (southern part of Japan), Kuma Hospital in Kobe (central part of Japan) and Ito Hospital in Tokyo (eastern part of Japan), so the study provided data on a cross section of Japanese patient populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thyrotoxic periodic paralysis (TPP), a disorder most commonly seen in Asian men, is characterized by abrupt onset of hypokalemia and paralysis.”
From Thyrotoxic Periodic Paralysis: Clinical Challenges (2014) · cites this paper as [2]
In the citing paper
“The incidence of TPP in Chinese and Japanese thyrotoxic patients has been reported at 1.8% and 1.9%, respectively [2], whereas in North Americans at 0.1%–0.2% [5].”
From Thyrotoxic Periodic Paralysis: Clinical Challenges (2014) · cites this paper as [2]
In the citing paper
“The incidence of TPP in Chinese and Japanese thyrotoxic patients has been reported at 1.8% and 1.9%, respectively [2], whereas in North Americans at 0.1%–0.2% [5].”
From Thyrotoxic Periodic Paralysis: Clinical Challenges (2014) · cites this paper as [2]
In the citing paper
“Thyrotoxic periodic paralysis (TPP) is more commonly reported in oriental Asians [2].”
From Thyrotoxic Periodic Paralysis: Clinical Challenges (2014) · cites this paper as [2]
Citations
Cited by
Sorted by citations
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
“In China and Japan 48 periodic paralysis has an incidence of 2% compared to 0.2% in North America 49 .”
InfluentialThyrotoxic Periodic Paralysis: A Diagnostic Challenge
Kung, A. W. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0356 · Cited by 371
“4% among female thyrotoxic patients in 1957 [2] .”
BackgroundPeriodic paralysis complicating thyrotoxicosis in Chinese.
McFadzean, A. J., & Yeung, R. (1967) · BMJ · doi:10.1136/bmj.1.5538.451 · Cited by 303
Clinical and Metabolic Features of Thyrotoxic Periodic Paralysis in 24 Episodes
Manoukian, M. A., Foote, J. A., & Crapo, L. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.6.601 · Cited by 255
Kelley, D. E. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2597 · Cited by 227
Lin, S.-H. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.1.99 · Cited by 254
Hypokalemic paralyses: A review of the etiologies, pathophysiology, presentation, and therapy
Stedwell, R. E., Allen, K., & Binder, L. S. (1992) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(92)90048-3 · Cited by 186
In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis.
Chan, A., Shinde, R., Chow, C. C., Cockram, C. S., & Swaminathan, R. (1991) · BMJ · doi:10.1136/bmj.303.6810.1096 · Cited by 160
Thyrotoxic periodic paralysis in a Chinese population
Ko, G. T. C., Chow, C. C., Yeung, V. T. F., Chan, H. H. L., LI, J. K. Y., & Cockram, C. S. (1996) · QJM · doi:10.1093/qjmed/89.6.463 · Cited by 160
Studies in familial periodic paralysis
SHY, G. M., Wanko, T., Rowley, P. T., et al. (1961) · Experimental Neurology · doi:10.1016/0014-4886(61)90006-1 · Cited by 138
Periodic paralysis and the sodium‐potassium pump
Layzer, R. B. (1982) · Annals of Neurology · doi:10.1002/ana.410110602 · Cited by 122
Chang, C.-C., Cheng, C.-J., Sung, C.-C., Chiueh, T.-S., Lee, C.-H., Chau, T., & Lin, S.-H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0381 · Cited by 114
Non-dystrophic myotonias and periodic paralyses
Lehmann‐Horn, F., Rüdel, R., & Ricker, K. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90009-9 · Cited by 111
Thyroid function and periodic paralysis
Engel, A. G. (1961) · The American Journal of Medicine · doi:10.1016/0002-9343(61)90104-8 · Cited by 103
Tassone, H., Moulin, A., & Henderson, S. O. (2004) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2003.05.004 · Cited by 93
Thyrotoxic Periodic Paralysis: Clinical Challenges
Vijayakumar, A., Ashwath, G., & Thimmappa, D. (2014) · Journal of Thyroid Research · doi:10.1155/2014/649502 · Cited by 88
“Thyrotoxic periodic paralysis (TPP) is more commonly reported in oriental Asians [2].”
RetractedAnalytic review: thyrotoxic periodic paralysis: a review
Pothiwala, P., & Levine, S. N. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066609358849 · Cited by 80
“Despite the fact that thyroid disease is more frequently diagnosed in women, the male-to-female ratio of TPP ranges from 4 to 20:1.(7,8) Population-based data from 1960 to 1965 demonstrated a 1.”
Hawkins, B. R., C., J. T., Lam, K. S. L., Wang, C. C. L., & YEUNG, R. T. T. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00220.x · Cited by 82
Hsieh, M. ‐., Lyu, R. ‐., Chang, W. ‐., Chang, K. ‐., Chen, C. ‐., Chang, H. ‐., Wu, Y. ‐., Chen, S. ‐., & Ro, L. ‐. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02132.x · Cited by 78
“The reasons for the male preponderance and the tendency of TPP onset between 20 and 40 years are unclear [2,3,10].”
BackgroundThyrotoxic periodic paralysis: clinical and molecular aspects
Falhammar, H., Thorén, M., & Calissendorff, J. (2012) · Endocrine · doi:10.1007/s12020-012-9777-x · Cited by 74
“Although thyrotoxicosis is more widespread in females than in males, the incidence of TPP is 22–76 times more frequent in males compared to females [1, 2, 25].”
BackgroundElectrocardiographic Manifestations in Patients with Thyrotoxic Periodic Paralysis
Hsu, Y.-J., Lin, Y.-F., Chau, T., Lin, S.-H., Liou, J.-T., & Kuo, S.-W. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200309000-00004 · Cited by 70
Cheng, C.-J., Lin, S.-H., Lo, Y.-F., Yang, S.-S., Hsu, Y.-J., Cannon, S. C., & Huang, C.-L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.a111.249656 · Cited by 6
HLA and Thyrotoxic Periodic Paralysis in Japanese Patients
TAMAI, H., TANAKA, K., KOMAKI, G., MATSUBAYASHI, S., HIROTA, Y., MORI, K., KUMA, K., KUMAGAI, L. F., & NAGATAKI, S. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1075 · Cited by 62
Self-citation(2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00032-6 · Cited by 61
Shishiba, Y., Shimizu, T., Saito, T., & Shizume, K. (1972) · Metabolism · doi:10.1016/0026-0495(72)90071-6 · Cited by 56
Self-citationMA, J. T. C., Wang, C., Lam, K. S. L., YEUNG, R. T. T., CHAN, F. L., BOEY, J., Cheung, P., Coghlan, J. P., Scoggins, B. A., & Stockigt, J. R. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a068058 · Cited by 46
Neuromuscular complications of thyrotoxicosis
Kung, A. W. C. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02909.x · Cited by 46
Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP)
Soonthornpun, S., Setasuban, W., & Thamprasit, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03395.x · Cited by 47
Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis
SHIZUME, K., Shishiba, Y., Sakuma, M., Yamauchi, H., Nakao, K., & Okinaka, S. (1966) · Metabolism · doi:10.1016/0026-0495(66)90035-7 · Cited by 44
Self-citationRamsay, I. (1968) · Postgraduate Medical Journal · doi:10.1136/pgmj.44.511.385 · Cited by 45
Hyperthyroidism And Periodic Paralysis
JACKMAN, R. L. (1964) · Archives of Internal Medicine · doi:10.1001/archinte.1964.00280110037007 · Cited by 45
Electrocardiographic changes in thyrotoxic periodic paralysis
Ee, B., Med, M., & Cheah, J. S. (1979) · Journal of Electrocardiology · doi:10.1016/s0022-0736(79)80059-x · Cited by 43
Riggs, J. E. (1988) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30856-9 · Cited by 42
Thyrotoxic Hypokalemic Periodic Paralysis: Report of Four Cases in Black American Males1
Kilpatrick, R. E., Seiler-Smith, S., & Levine, S. N. (1994) · Thyroid® · doi:10.1089/thy.1994.4.441 · Cited by 41
“Since that time it has been observed that TPP occurs predominately in the Asian populations with a high predilection for males compared to females (4-20:1) (8,9).”
InfluentialSHIZUME, K., Shishiba, Y., Kuma, K., Noguchi, S., Tajiri, J., Ito, K., & Noh, J. Y. (1992) · Endocrinologia Japonica · doi:10.1507/endocrj1954.39.315 · Cited by 40
“In 1957, we reported a rather high incidence of the association of periodic paralysis and hyperthyroidism in Japan [1].”
BackgroundSelf-citationHypokalemic Periodic Paralysis due to the Sjögren Syndrome in Chinese Patients
Pun, K.-K., Wong, C.-K., Tsui, E. Y.-L., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-5-405 · Cited by 41
Thyrotoxic hypokalemic periodic paralysis: An overlooked pathology in western countries
Pompeo, A., Nepa, A., Maddestra, M., Feliziani, V., & Genovesi, N. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.03.003 · Cited by 40
“Its incidence has a characteristic preponderance in men [14], with a greater frequency, up to 70-fold with respect to women [2,29,30].”
BackgroundThyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone
Liu, Z., Braverman, L. E., & Malabanan, A. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.427 · Cited by 38
Hypokalemic Periodic Paralysis: a case report and review of the literature
Soule, B. P., & Simone, N. L. (2008) · Cases Journal · doi:10.1186/1757-1626-1-256 · Cited by 37
“hyperthyroid Japanese men [6,7].”
Thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia
Norris, K. C., Levine, B. S., & Ganesan, K. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90312-1 · Cited by 32
Ferreiro, J. E., Arguelles, D. J., & Rams, H. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90067-7 · Cited by 35
Goh, S. H. (2002) · Emergency Medicine Journal · doi:10.1136/emj.19.1.78 · Cited by 32
The genetic susceptibility to Graves' disease.
Tomer, Y., & Davies, T. (1997) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80678-7 · Cited by 46
Resnick, J. S., Dorman, J. D., & Engel, W. K. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90178-8 · Cited by 32
McArdle, B. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90137-2 · Cited by 32
Thyrotoxic periodic paralysis: an overview
Hsieh, C., Kuo, S., Pei, D., Hung, Y.-J., Fan, S. C., Wu, L.-I., He, C., Yang, T., Lian, W., & Lee, C.-H. (2004) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2004.418 · Cited by 31
Case Report: Thyrotoxic Periodic Paralysis in a Latin-American Taking Acetazolamide
Shulkin, D. J., Olson, B. R., & Levey, G. S. (1989) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198905000-00014 · Cited by 31
Abbasi, B., Sharif, Z. I., Sprabery, L. R., & Lopez, F. A. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181cbf567 · Cited by 30
Triiodothyronine (T3) toxicosis with hypokalemic periodic paralysis and ventricular tachycardia
Davison, E. T., & Davisond, M. J. (1995) · Journal of Electrocardiology · doi:10.1016/s0022-0736(05)80288-2 · Cited by 30
Walton, J. N. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90792-5 · Cited by 30
Miyashita, Y., Monden, T., Yamamoto, K., Matsumura, M., Kawagoe, N., Iwata, C., Banba, N., Hattori, Y., & Kasai, K. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1495 · Cited by 29
“A 25-year-old Japanese man was admitted to our hospital in October 2004 because of arm and leg muscle weakness.”
BackgroundInfluentialA thyrotropin-secreting pituitary adenoma as a cause of thyrotoxic periodic paralysis
ALINGS, A. M. W., Fliers, E., de Herder, W. W., Hofland, L. J., Sluiter, H. E., Links, T. P., van der Hoeven, J. H., & Wiersinga, W. M. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350802 · Cited by 28
Biering, H., Bauditz, J., Pirlich, M., Lochs, H., & Gerl, H. (2003) · Hormone Research in Paediatrics · doi:10.1159/000070630 · Cited by 28
“Thyrotoxic periodic paralysis (TPP), a syndrome characterized by paralysis and hypokalaemia in patients with hyperthyroidism, is a relatively frequent complication of thyrotoxicosis in Asian populations with a high predominance in males, but a rare event in Caucasians [”
BackgroundAoi, N., Nakayama, T., Tahira, Y., et al. (2007) · Endocrine · doi:10.1007/s12020-007-0024-9 · Cited by 28
Tang, N. L. S., Chow, C. C., Ko, G. T. C., Tai, M. H. L., Kwok, R., Yao, X., & Cockram, C. S. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02079.x · Cited by 26
Thyrotoxic Periodic Paralysis Associated with a Mutation in the Sodium Channel Gene SCN4A
Lane, A., Markarian, K., & Braziunene, I. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.12.1679 · Cited by 27
Akar, S., Çömlekçi, A., Bırlık, M., Önen, F., Sarı, İ., Gürler, O., Bekiş, R., & Akkoç, N. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.149 · Cited by 25
“2% of hyperthyroid Japanese males [1, 12] and 12.”
BackgroundHypokalemic, Hypophosphatemic Thyrotoxic Periodic Paralysis
Nora, N. A., & Berns, A. S. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80060-5 · Cited by 26
Thyrotoxicosis and Paraparesis in a Young Woman: Case Report and Review of the Literature
Mellgren, G., Bleskestad, I. H., Aanderud, S., & Bindoff, L. A. (2002) · Thyroid · doi:10.1089/105072502753452002 · Cited by 25
“TPP has been reported to occur in 12.9% of hyperthyroid Chinese males (3) and in 4.3% to 8.2% of hyperthyroid Japanese males (2,10).”
InfluentialWang, C., & Yeung, R. T. T. (1985) · Contraception · doi:10.1016/0010-7824(85)90047-2 · Cited by 25
Neurologic and Muscular Manifestations of Hyperthyroidism
Logothetis, J. A. (1961) · Archives of Neurology · doi:10.1001/archneur.1961.00450170071009 · Cited by 25
Etiologic and Therapeutic Analysis in Patients with Hypokalemic Nonperiodic Paralysis
Sung, C., Cheng, C., Chiang, W., Chau, T., Hsu, Y., Yang, S.-S., & Lin, S. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.09.027 · Cited by 23
Thyrotoxic periodic paralysis due to excessive L-thyroxine replacement in a Caucasian man
Hannon, M. J., Behan, L. A., & Agha, A. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009012 · Cited by 22
Zhao, S., Liu, W., Liang, J., Gao, G.-Q., Zhang, X., Yao, Y., Wang, H., Yuan, F., Xue, L., Ma, Y., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3348 · Cited by 22
Thyrotoxic Periodic Paralysis: An Underdiagnosed and Underrecognized Condition
Tella, S. H., & Kommalapati, A. (2015) · Cureus · doi:10.7759/cureus.342 · Cited by 22
“The age of onset of symptoms in TPP is between 20 and 39 years in approximately 80% of patients [8-12].”
BackgroundThyrotoxic Periodic Paralysis in a Hispanic Man
Saeian, K. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380030214033 · Cited by 22
Hypokalemic periodic paralysis. Experimental precipitation with sodium liothyronine
Okihiro, M. M. (1966) · JAMA · doi:10.1001/jama.198.8.949 · Cited by 22
Verma, V., Kumar, Y., Kotwal, N., Upreti, V., Kumar, K. V. S. H., Singh, Y. P., & Menon, A. S. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_335_18 · Cited by 21
Norris, F. H. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00480010106009 · Cited by 21
A case of thyrotropin (TSH)-secreting tumor complicated by periodic paralysis.
KISO, Y., Yoshida, K., KAISE, K., KAISE, N., Masuda, T., Ando, N., Kameyama, M., Yamamoto, M., SAKURADA, T., & YOSHINAGA, K. (1990) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.29.399 · Cited by 21
Thyrotoxic periodic paralysis: case report and review of the literature
Vardhan Garla, V., Gunturu, M., Reddy Kovvuru, K., & Abdul Salim, S. (2018) · Electronic Physician · doi:10.19082/7174 · Cited by 20
“(1, 25-27) The severity of the episodes can range from weakness to complete paralysis and the duration can range from a few hours to 3 days (28).”
BackgroundKokenge, F., & Moenig, H. (2005) · The Endocrinologist · doi:10.1097/01.ten.0000179017.46464.58 · Cited by 20
SPILLANE, J. D. (1972) · BMJ · doi:10.1136/bmj.2.5812.506 · Cited by 20
Yao, Y., Fan, L., Zhang, X., Xiao, Z., Long, Y., & Tian, H. (2013) · Thyroid · doi:10.1089/thy.2011.0493 · Cited by 19
“5% of male hyperthyroid patients) in Japan (2,5,6) and 1.”
InfluentialDrug-Induced Thyrotoxic Periodic Paralysis
Kane, M. P., & Busch, R. S. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g543 · Cited by 20
Muscle Cramps in Chronic Thyrotoxic Myopathy
Araki, S. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00480030093010 · Cited by 19
Thyrotoxic periodic paralysis: diversity in America
Patel, H., Wilches, L. V., & Guerrero, J. (2014) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2013.08.104 · Cited by 19
Severe hypokalemia in thyrotoxic periodic paralysis
Miller, D., Del-Castillo, J. G., & Tsang, T.-K. (1989) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(89)90279-9 · Cited by 19
KUSAKABE, T., Yoshida, M., & NISHIKAWA, M. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-4-730 · Cited by 18
Naik, S., Talwar, D., Acharya, S., Kumar, S., & Shrivastava, D. (2021) · Cureus · doi:10.7759/cureus.19566 · Cited by 17
“In two-thirds of patients, overt biochemical hyperthyroidism (suppressed TSH, elevated free T4) is present, often in the absence of clinical symptoms of thyrotoxicosis, and resolves with the resolution of the hyperemesis [3,4].”
BackgroundFamilial thyrotoxic periodic paralysis.
Kufs, W. M., McBiles, M., & Jurney, T. H. (1989) · PubMed · Cited by 17
Thyrotoxic period paralysis: report of three cases and review of the literature.
PAPADOPOULUS, K. I., DIEP, T., Cleland, B., & LUNN, N. W. (1997) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1997.tb00011.x · Cited by 17
Unusual Manifestations of Graves's Disease
Locke, W. (1967) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)33005-x · Cited by 17
Chang, R. Y. K., Lang, B. H., Chan, A. C. W., & Wong, K. P. (2014) · International Journal of Endocrinology · doi:10.1155/2014/949068 · Cited by 15
Thyrotoxic periodic paralysis: Two case studies
DARROW, M., Brammer, W. K., & Rowley, A. (1995) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(95)80641-5 · Cited by 15
Παππά, Θ., Papanastasiou, L., Markou, Α., Androulakis, I. I., Kontogeorgos, G., Seretis, A., & Piaditis, G. P. (2010) · HORMONES · doi:10.14310/horm.2002.1257 · Cited by 15
Ruff, R. L., & Shapiro, B. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_53 · Cited by 16
ERYTHROCYTE SODIUM‐POTASSIUM PUMP IN THYROTOXIC PERIODIC PARALYSIS
Lam, K. S. L., YEUNG, R. T. T., BENSON, E. A., et al. (1989) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1989.tb01664.x · Cited by 15
Thyrotoxic periodic paralysis and anesthesia report of a case and literature review
Diedrich, D. A., & Wedel, D. J. (2006) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2005.08.016 · Cited by 14
“9% [26] and 8.”
Thyrotoxic hypokalaemic paralysis in a Black man
Salifu, M. O. (2001) · QJM · doi:10.1093/qjmed/94.11.659 · Cited by 15
Influences of thyroid status and sympathoadrenal system on extrarenal potassium disposal
Kubota, K., & Ingbar, S. H. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.3.e428 · Cited by 14
Hyperthyroidism with periodic paralysis.
Feldman, D. L., & Goldberg, W. M. (1969) · PubMed · Cited by 14
Thyrotoxic Periodic Paralysis in Mexican Mestizo Patients
Nellen, H., Mercado, M., Mendoza, V., Villanueva, S., Pérez‐Rodríguez, M., Hernández, A., & Arellano, J. (1999) · Archives of Medical Research · doi:10.1016/s0188-0128(98)00014-1 · Cited by 14
Hypokalaemic thyrotoxic periodic paralysis: case report and review of an Oriental syndrome
VanDam, G., Reisman, Y., & VANWIERINGEN, K. (1996) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(96)00014-9 · Cited by 13
Thyrotoxic Periodic Paralysis Associated with Transient Thyrotoxicosis Due to Painless Thyroiditis
Oh, S.-B., Ahn, J., Oh, M. Y., Choi, B. G., Kang, J. H., Jeon, Y. K., Kim, S. S., Kim, B. H., Kim, Y. K., & Kim, I. J. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.7.822 · Cited by 14
“9%, respectively (2), whereas in North Americans at 0.”
BackgroundLim, A., Kek, P., & Soh, W. H. (2013) · Singapore Medical Journal · doi:10.11622/smedj.2013145 · Cited by 13
“(2) Although it is relatively common to encounter myositis as a complication of thyrotoxic periodic paralysis (TPP) in the Asian population,(5,6) the development of myositis after treatment of Graves’ disease (GD) is rare.”
BackgroundJongjaroenprasert, W., Chanprasertyotin, S., Butadej, S., Nakasatien, S., Charatcharoenwitthaya, N., Himathongkam, T., & Ongphiphadhanakul, B. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03083.x · Cited by 13
Sanghvi, L. M., Gupta, K., Banerjee, K., et al. (1959) · The American Journal of Medicine · doi:10.1016/0002-9343(59)90198-6 · Cited by 13
Kim, T. Y., Song, J. Y., Kim, W. B., & Shong, Y. K. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02264.x · Cited by 13
THYROTOXICOSIS AND RENAL TUBULAR ACIDOSIS PRESENTING AS HYPOKALAEMIC PARALYSIS
Szeto, C., Chow, C. C., LI, K. Y., KO, T. C., Yeung, V. T. F., & Cockram, C. S. (1996) · Lara D. Veeken · doi:10.1093/rheumatology/35.3.289 · Cited by 12
“Most cases described so far have occurred in Orientals [3, 4], and the incidence of hypokalaemic paralysis in thyrotoxic patients in these localities approaches 2%.”
Background
Metadata
- Authors
- OKINAKA, S., SHIZUME, K., UNO, S., WATANABE, A., IRIE, M., NOGUCHI, A., KUMA, S., KUMA, K., & ITO, T.
- Affiliations
- Ito Hospital (JP)
- ORCID
- WATANABE, AKIRA
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1957-12
- Volume
- 17
- Issue
- 12
- Pages
- 1454-1459
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087117762
- Cited by
- 206
- References
- 0
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 7 · 2012: 7
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- periodic paralysis, hyperthyroidism, hypokalemic periodic paralysis, thyrotoxic periodic paralysis, incidence, Japanese patients
- MeSH terms
- Humans, Hyperthyroidism, Japan, Paralysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review